中国循证心血管医学杂志
中國循證心血管醫學雜誌
중국순증심혈관의학잡지
CHINESE JOURNAL OF EVIDENCE-BASES CARDIOVASCULAR MEDICINE
2013年
4期
394-395
,共2页
周江%郭靖涛%王青雷%王福华%代燕燕%石鑫
週江%郭靖濤%王青雷%王福華%代燕燕%石鑫
주강%곽정도%왕청뢰%왕복화%대연연%석흠
冠心病%心绞痛%益心舒胶囊%硝酸异山梨酯片
冠心病%心絞痛%益心舒膠囊%硝痠異山梨酯片
관심병%심교통%익심서효낭%초산이산리지편
Coronary heart disease%Angina pectoris%Yixinshu Capsules%Isosorbide dinitrate tablets
目的观察益心舒胶囊治疗心绞痛的临床疗效。方法纳入2011年1月~2011年12月承德市中心医院诊断心绞痛患者197例,随机分为对照组(n=98)和治疗组(n=99),对照组服用硝酸异山梨酯片(消心痛)10 mg(tid),治疗组在对照组基础上联合益心舒胶囊3粒(tid),疗程2个月。观察治疗前后心绞痛发作情况、血压和心率变化以及心电图改变情况,记录益心舒胶囊治疗心绞痛的有效率及在治疗期间出现的不良反应(包括头痛、头晕及全身皮肤改变等)。结果治疗组心绞痛治疗有效率高于对照组(95.96%vs.73.47%),差异有统计学意义(P<0.01)。经过治疗后,两组心率[(73.6±6.2)次/分vs.(75.8±6.1)次/分]、血压[收缩压(SBP):(137.8±19.4)mmHg vs.(136.8±18.9)mmHg;舒张压(DBP):(84.5±11.7)mmHg vs.(83.6±11.8)mmHg]均无统计学差异(P<0.05),且均未见不良反应。结论益心舒胶囊可提高心绞痛治疗效果,且安全性良好。
目的觀察益心舒膠囊治療心絞痛的臨床療效。方法納入2011年1月~2011年12月承德市中心醫院診斷心絞痛患者197例,隨機分為對照組(n=98)和治療組(n=99),對照組服用硝痠異山梨酯片(消心痛)10 mg(tid),治療組在對照組基礎上聯閤益心舒膠囊3粒(tid),療程2箇月。觀察治療前後心絞痛髮作情況、血壓和心率變化以及心電圖改變情況,記錄益心舒膠囊治療心絞痛的有效率及在治療期間齣現的不良反應(包括頭痛、頭暈及全身皮膚改變等)。結果治療組心絞痛治療有效率高于對照組(95.96%vs.73.47%),差異有統計學意義(P<0.01)。經過治療後,兩組心率[(73.6±6.2)次/分vs.(75.8±6.1)次/分]、血壓[收縮壓(SBP):(137.8±19.4)mmHg vs.(136.8±18.9)mmHg;舒張壓(DBP):(84.5±11.7)mmHg vs.(83.6±11.8)mmHg]均無統計學差異(P<0.05),且均未見不良反應。結論益心舒膠囊可提高心絞痛治療效果,且安全性良好。
목적관찰익심서효낭치료심교통적림상료효。방법납입2011년1월~2011년12월승덕시중심의원진단심교통환자197례,수궤분위대조조(n=98)화치료조(n=99),대조조복용초산이산리지편(소심통)10 mg(tid),치료조재대조조기출상연합익심서효낭3립(tid),료정2개월。관찰치료전후심교통발작정황、혈압화심솔변화이급심전도개변정황,기록익심서효낭치료심교통적유효솔급재치료기간출현적불량반응(포괄두통、두훈급전신피부개변등)。결과치료조심교통치료유효솔고우대조조(95.96%vs.73.47%),차이유통계학의의(P<0.01)。경과치료후,량조심솔[(73.6±6.2)차/분vs.(75.8±6.1)차/분]、혈압[수축압(SBP):(137.8±19.4)mmHg vs.(136.8±18.9)mmHg;서장압(DBP):(84.5±11.7)mmHg vs.(83.6±11.8)mmHg]균무통계학차이(P<0.05),차균미견불량반응。결론익심서효낭가제고심교통치료효과,차안전성량호。
Objective To observe the curative effect of Yixinshu Capsules on angina pectoris (AP). Methods The patients (n=197) with AP were chosen from the Central Hospital of Chengde City from Jan. 2011 to Dec. 2011, and then randomly divided into control group (n=98) and treatment group (n=99). The control group was given isosorbide dinitrate tablets (Xioaxintong, 10 mg/tid) and treatment group was additionally given Yixinshu Capsules (3 capsules/tid) for two months. The attack of AP and changes of blood pressure, heart rate and electrocardiogram (ECG) were observed before and after treatment. The occurrence of adverse events (including headache, dizziness and changes of whole body skin) was recorded during treatment. The standard of curative effect was set as AP symptoms disappeared, attack frequency of AP reduced by 50%and AP grades reduced over 1 grade or ST segment of ECG rose again equaled to or over 0.5 mV. Results The curative effect on AP was higher in treatment group than that in control group (95.96%vs. 73.47%, P<0.01). There were no statistical differences (P>0.05) in heart rate [(73.6± 6.2) times/min vs. (75.8±6.1) times/min] and blood pressure [SBP:(137.8±19.4) mmHg vs. (136.8±18.9) mmHg, DBP:(84.5±11.7) mmHg vs. (83.6±11.8) mmHg] between two groups. There were no adverse reactions observed. Conclusion Yixinshu Capsules can improve the curative effect on AP with higher safety.